In this issue:
Infection risk following intravenous iron
Ibrutinib for rituximab-refractory Waldenström macroglobulinaemia
Real-world ruxolitinib dosing for polycythaemia vera
microRNA profile and disease severity in sickle cell anaemia
Multidrug-resistant GI infections in paediatric SCT recipients
Vemurafenib in paediatric BRAF V600E+ Langerhans cell histiocytosis
BNT162b2 COVID vaccine effectiveness in haematological neoplasms
Neutralising antibody response to COVID vaccines in Waldenström macroglobulinaemia
Allogeneic SCT in MDS using treosulfan-based vs. other conditioning
Ixazomib for switch-maintenance GVHD prophylaxis after allogeneic SCT
Please login below to download this issue (PDF)